Seres Therapeutics, Inc. - COMMON STOCK (MCRB)

CUSIP: 81750R102

Q1 2023 13F Holders as of 31 Mar 2023

Holder snapshot 7 signals
Share change
-392,010
Put/Call ratio
98%
SEC-reported price per share
$5.67
Number of holders
123
Value change
-$2,181,787
Number of buys
59
Open additional details 1 more signal available
Number of sells
56
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
170,403,883

Security key

81750R102

Report period

Q1 2023

Institutions

123

Top holders

10

Ownership snapshot

Top reported holders of MCRB - Seres Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Nutritional Health LTP Fu...
Disclosed value leader
Flagship Pioneering, LLC
Comparable rows
0/15
Latest evidence
31 Dec 2022
3/4/5 13F Highest disclosed value: $129,455,452 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Flagship Pioneering, LLC has the largest disclosed position value at $129.46M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Flagship Pioneering, LLC's linked filing trail.
Disclosed position value Top 5
Nutritional Health LTP Fund Gener... $31.72M
Flagship Pioneering Fund VII Gene... $7.86M
Flagship Pioneering, LLC $129.46M
FMR LLC $104.66M
FEDERATED HERMES, INC. $101.28M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Nutritional Health LTP Fund General Partner LLC
3/4/5
10%+ Owner
—
denominator unverified
$31,715,635
23,493,063 shares
— 05 Jul 2022
Flagship Pioneering Fund VII General Partner LLC
3/4/5
10%+ Owner
—
denominator unverified
$7,864,418
5,825,495 shares
— 05 Jul 2022
Flagship Pioneering, LLC
13F
Company
13F
—
denominator unverified
$129,455,452
23,117,045 shares
— 31 Dec 2022
FMR LLC
13F
Company
13F
—
denominator unverified
$104,657,061
18,688,761 shares
— 31 Dec 2022
FEDERATED HERMES, INC.
13F
Company
13F
—
denominator unverified
$101,281,253
18,085,938 shares
— 31 Dec 2022
Janus Henderson Group Ltd.
13F
Company
13F
—
denominator unverified
$63,001,442
11,248,292 shares
— 31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
123
Shares
104,749,292
Rows available
123
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q3 2025 Across Filers

Q3 2025 holders
1
Q1 2023 holders
123
Holder diff
122
Investor Q3 2025 Shares Q1 2023 Shares Share Diff Share Chg % Q3 2025 value Q1 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .